Literature DB >> 9874140

A simple, reproducible technique for establishing leptomeningeal tumors in nude rats.

K H Janczewski1, C L Chalk, R B Pyles, L M Parysek, L W Unger, R E Warnick.   

Abstract

The incidence of leptomeningeal carcinomatosis is on the rise and current treatment modalities have limited efficacy. The development of new treatment strategies has been hampered by the lack of an appropriate animal model that accurately parallels the clinical condition. We have developed a new surgical technique for the establishment of leptomeningeal tumors in rats. Our technique is simple, reproducible and associated with low morbidity and mortality. Tumor implantation resulted in a defined neurological endpoint and a reproducible time course of disease progression using both human medulloblastoma and breast carcinoma cell lines. This animal model provides an appropriate system for testing conventional and new biologic therapies in both early and late stages of leptomeningeal disease.

Entities:  

Mesh:

Year:  1998        PMID: 9874140     DOI: 10.1016/s0165-0270(98)00115-0

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  3 in total

1.  Characterization of ultrasound-mediated delivery of trastuzumab to normal and pathologic spinal cord tissue.

Authors:  Paige Smith; Natalia Ogrodnik; Janani Satkunarajah; Meaghan A O'Reilly
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

Review 2.  Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System.

Authors:  Mohini Singh; David Bakhshinyan; Chitra Venugopal; Sheila K Singh
Journal:  Front Oncol       Date:  2017-09-19       Impact factor: 6.244

3.  Preliminary Investigation of Focused Ultrasound-Facilitated Drug Delivery for the Treatment of Leptomeningeal Metastases.

Authors:  Meaghan A O'Reilly; Tricia Chinnery; My-Linh Yee; Sheng-Kai Wu; Kullervo Hynynen; Robert S Kerbel; Gregory J Czarnota; Kathleen I Pritchard; Arjun Sahgal
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.